Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national
3
×
national blog main
national top stories
new york top stories
san francisco top stories
alnylam pharmaceuticals
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
drug prices
fda
gene therapy
indiana blog main
indiana top stories
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2019
activism
acute hepatic porphyria
ambys medicines
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
athenex
What
drug
3
×
therapy
3
×
bio
fda
gene
patients
roundup
advanced
alnylam’s
approval
approved
aren’t
atrophy
bff
conference
daily
deals
developers
devoted
disease
drugs
easl
evrysdi
form
friday
green
help
home
imminent
intended
kicked
lights
liquid
liver
long
major
medicare
medicine
moves
muscular
Language
unset
Current search:
drug
×
national
×
therapy
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
